|
Variables
|
Univariate analysis
|
Multivariate analysis
|
|---|
|
HR
|
95% CI
|
p value
|
HR
|
95% CI
|
p value
|
|---|
|
Age (< 50 vs. ≥ 50)
|
1.031
|
0.670–1.231
|
0.747
| | | |
|
Tumor size (< 20 vs. ≥ 20) (mm)
|
2.918
|
1.554–4.609
|
< 0.001*
|
1.895
|
0.881–2.805
|
0.493
|
|
TNM stage (I-II vs. III)
|
1.732
|
1.275–2.618
|
0.013*
|
1.787
|
1.271–2.991
|
0.015*
|
|
Histological differentiation (I-II vs. III)
|
1.078
|
0.487–1.499
|
0.718
| | | |
|
Positive lymph node ratio (< 0.21 vs. ≥ 0.21)
|
2.004
|
0.812–2.260
|
0.083
| | | |
|
ER (pos vs. neg)
|
0.714
|
0.513–1.919
|
0.057
| | | |
|
PR (pos vs. neg)
|
0.721
|
0.486–1.542
|
0.501
| | | |
|
Herb2 (pos vs. neg)
|
1.405
|
1.207–2.711
|
0.029*
|
1.193
|
0.814–2.569
|
0.807
|
|
PD-L1 expression (pos vs. neg)
|
0.610
|
0.352–0.903
|
< 0.001*
|
0.569
|
0.318–0.830
|
< 0.001*
|
|
TNBC (yes vs. no)
|
1.902
|
0.890–2.925
|
0.604
| | | |
- HR Hazard ratio, CI Confidence interval, *Statistically significant, p < 0.05
